임상 레이더 AI | ||
|---|---|---|
임상시험 NCT07439991은(는) 폐암 진단, 심부 정맥 혈전증 (DVT), 정맥 혈전색전증 (VTE)에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요. | ||
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery 900 머신 러닝 관찰 연구
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT07439991은(는) 폐암 진단, 심부 정맥 혈전증 (DVT), 정맥 혈전색전증 (VTE)에 대해 알아보는 관찰연구입니다. 현재 상태는 모집중이며, 연구는 2024년 11월 1일에 시작되어 900명의 참여자를 모집하고 있습니다. The First Hospital of Jilin University이(가) 진행하며, 2029년 11월 30일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2026년 2월 27일에 갱신되었습니다.
간단한 개요
The goal of this observational study is to learn about the risk factors and prediction of postoperative venous thromboembolism (VTE) in patients undergoing lung cancer surgery. The main question it aims to answer is:
Which clinical, surgical, and laboratory factors are associated with the development of postoperative deep vein thrombosis (DVT) in lung cancer surgery patients, and can machine learning models accurate...
더 보기공식 제목
Prospective Cohort Study on Risk Factors and Machine Learning-Based Prediction of Postoperative Venous Thromboembolism in Patients Undergoing Lung Cancer Surgery
질환명
폐암 진단심부 정맥 혈전증 (DVT)정맥 혈전색전증 (VTE)기타 연구 식별자
- JLUThorSurg-VTE02
NCT 번호
실제 연구 시작일
2024-11-01
최신 업데이트 게시
2026-02-27
예상 연구 완료일
2029-11-30
계획된 등록 인원
900
연구종류
관찰연구
상태
모집중
시험군 / 개입
| 참가자 그룹/시험군 | 개입/치료 |
|---|---|
VTE Group Adult patients undergoing lung cancer surgery who develop postoperative deep vein thrombosis (DVT) within 30 days. Perioperative clinical, laboratory, and imaging data will be collected to identify risk factors and build predictive models. | Prospective Perioperative Data Collection The intervention involves the prospective collection of perioperative clinical, laboratory, and imaging data from adult patients undergoing lung cancer surgery. No therapeutic or diagnostic procedures beyond standard care are applied. Collected data will be used to identify risk factors for postoperative deep vein thrombosis (DVT) and to develop machine learning-based predictive models. |
Non-VTE Group Adult patients undergoing lung cancer surgery who do not develop postoperative DVT within 30 days. Perioperative clinical, laboratory, and imaging data will be collected for comparison with the VTE group. | Prospective Perioperative Data Collection The intervention involves the prospective collection of perioperative clinical, laboratory, and imaging data from adult patients undergoing lung cancer surgery. No therapeutic or diagnostic procedures beyond standard care are applied. Collected data will be used to identify risk factors for postoperative deep vein thrombosis (DVT) and to develop machine learning-based predictive models. |
주요결과변수
이차결과변수
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Incidence of postoperative deep vein thrombosis (DVT) in lung cancer surgery patients | The primary outcome is the occurrence of postoperative deep vein thrombosis (DVT) within 30 days after lung cancer surgery, confirmed by Doppler ultrasound of the lower extremities. Perioperative clinical, laboratory, and imaging variables will be collected prospectively and analyzed to identify risk factors and develop machine learning-based predictive models for individual DVT risk. | From the day of lung cancer surgery to 30 days postoperatively |
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Identification of perioperative risk factors for postoperative deep vein thrombosis (DVT) in lung cancer surgery patients | Secondary outcomes include the evaluation of clinical, surgical, and laboratory variables associated with postoperative DVT within 30 days. Variables such as age, sex, BMI, comorbidities, tumor characteristics, operative details, and perioperative laboratory results will be analyzed using multivariate logistic regression and machine learning models to identify independent predictors of DVT. | From the day of surgery to 30 days postoperatively |
참여 도우미
적격성 기준
연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
- Age ≥ 18 years
- Patients undergoing surgical resection for lung cancer
- Postoperative hospital stay ≥ 48 hours
- Availability of perioperative clinical, laboratory, and imaging data
- Willingness to provide informed consent and participate in 30-day follow-up
- Pre-existing deep vein thrombosis (DVT) or pulmonary embolism (PE) before surgery
- Preoperative or ongoing anticoagulation therapy for ≥ 2 weeks
- Severe coagulation disorders or bleeding diseases
- Severe hepatic, renal, or hematologic dysfunction, or uncontrolled systemic infection
- Concurrent major organ surgery (e.g., cardiac, liver surgery)
- Pregnancy or lactation
- Incomplete postoperative follow-up data
The First Hospital of Jilin University연구 대표 연락처
연락처: Wei Liu, 86-13596083366, [email protected]
1 1개국에 임상시험 장소
Jilin
The First Hospital of Jilin University, Department of Thoracic Surgery, Changchun, Jilin, 130021, China
Wei Liu, 연락처, 86-13596083366, [email protected]
모집중